egfr
美 
英
- 網絡表皮生長因子受體(epidermal growth factor receptor)；腎小球濾過率；上皮生長因子受體
例句
Therapeutics targeting epidermal growth factor receptor (EGFR) are unable to effectively inhibit tumor growth in a majority of cases.
在絕大多數的腫瘤患者中單獨靶向EGFR受體并不能夠有效的抑制腫瘤生長。
Results: Expression of EGFR in non-atrophic gastritis was the lowest among the various gastric mucosal lesions (P01).
結果：EGFR在非萎縮性胃炎組織中的表達顯著低于其他胃黏膜病變組織（P0.01）；
But the generally limited response to these treatments has caused cancer experts to wonder if EGFR's role in the disease is limited as well.
但腫瘤對這種治療方案的反應總體上是有限的，這使得腫瘤學家們開始懷疑EGFR在疾病發展過程中的作用是否也是有限的。
Inhibition of EGFR may be a promising adjuvant in chemotherapeutic strategy in the treatment of the dismal disease.
對EGFR的抑制對于這個前景黯淡的疾病來說，不失為一個有希望的輔助化療手段。
Interpretation: EGFR-inhibiting antibodies compromised the renal magnesium retention capacity, leading to hypomagnesaemia in most patients.
解釋：抗EGFR抗體損害腎臟對鎂重吸收能力，導致大部分患者血鎂過低。
Methods: Immunohistochemistry was used to examine the immunolocalization of EGFR during mouse first lower molar development.
方法：用免疫組織化學檢測表皮生長因子受體（EGFR）在小鼠下頜第一磨牙牙胚發育過程中的定位。
In the first set of experiments, the researchers demonstrated that the kinase domain of EGFR is normally maintained in the off state.
在試驗的第一階段，研究者證明，EGFR的激酶結構域在通常情況下處于關閉的狀態。
The molecular targeted drugs include epidermal growth factor receptor(EGFR) inhibitors, angiogenesis inhibitors and apoptosis promoters.
分子靶向治療藥物包括表皮生長因子受體抑制藥、腫瘤新生血管生成抑制藥和凋亡誘導藥等。
Irrespective of pathology, anti-EGFR monoclonal antibody-induced severe hypomagnesaemia does not occur in all patients.
不管低鎂血癥發病病理學，抗EGFR單克隆抗體引起的嚴重低鎂血癥并非在所有的治療患者身上發生。
Isoflavone . Inhibitor of EGFR tyrosine kinase, blocking phosphatidylinositol turnover.
異黃酮類。抑制EGFR酪氨酸激酶。阻斷磷脂酰肌糖的翻轉。
Objective To investigate the relationship of epidermal growth factor (EGF) and its receptor(EGFR) with fetal birth weight.
目的探討表皮生長因子（EGF）及其受體與胎兒出生體重的關系。
Abstract: Objective To determine the role of epidermal growth factor receptor (EGFR) signaling in bone development in mice.
目的：探討表皮生長因子受體（EGFR）信號轉導系統在小鼠骨胳發育中的作用。
Objective As EGFR inhibitor, Cetuximab has been widely used in several solid tumors, and has perfect therapeutic effect and security.
目的作為EGFR抑制劑，西妥昔單抗在多種實體瘤中應用日益廣泛，顯示出良好的療效和安全性。
To determine the role of epidermal growth factor receptor (EGFR) signaling in endochondral ossification.
目的：探討表皮生長因子受體（EGFR）信號轉導在軟骨內骨化中的作用。
A total of 2281 patients with NSCLC were screened for EGFR mutations in their tumors and, of this group, 327 had mutations.
對總共2281名NSCLC患者腫瘤組織進行EGFR變異篩查。在這些患者中，327例患者檢測到變異。
In their structural studies, those scientists had found only the active conformation of EGFR in their protein crystals.
在他們的結構研究中，這些科學家已經發現，在他們制備的蛋白質晶體中，只存在活性構象的EGFR。
Estimated glomerular filtration rate (eGFR) and diastolic blood pressure showed no significant seasonal variations.
而患者的估計腎小球濾過率（eGFR）和舒張壓則沒有顯示出明顯的季節性變化。
The invention provides methods for the treatment of tyrosine kinase inhibitor resistant cancers with anti-EGFR antibodies.
本發明提供了使用抗EGFR抗體治療抗酪氨酸激酶抑制劑的癌癥的方法。
Activating mutations in EGFR in cancer cells from patients who had a response to these drugs were subsequently discovered.
隨后，在對這個藥物敏感的病人癌細胞身上，發現了表皮生長因子的突變。
Displays cytostatic and cytotoxic activity. Inhibitor of EGFR kinase. Shows antiangiogenic activity.
顯示細胞生長抑制和細胞毒活性。EGFR激酶抑制劑。有抗血管生成活性。
Erbitux slows the progression of colorectal cancer, but the drug's activity does not correlate with expression of EGFR in such tumours.
艾比特思延緩大腸癌的發展速度，但其的活性和表皮生長因子受體在這類腫瘤中的表達并沒有聯系。
an increase in the number of cells was associated with tumor progression, with the emergence of additional EGFR mutations in some cases.
捕獲細胞的數量增加與腫瘤進展相聯系，在一些患者與出現附加的EGFR突變相聯系。
The results also demonstrate that EGFR signaling pathway is an important target in pancreatic cancer.
該研究也揭示了EGFR通路在胰腺癌的治療中是一個重要的靶點。
Conclusions: Basal cytokeratin and EGFR expression are both highly prevalent among triple-negative breast cancers.
結論：三陰乳腺癌均高表達基底細胞角蛋白和EGFR。
EGFR inhibitor has got a promising efficacy in the treatment of non-small cell lung cancer and head and neck tumor.
表皮生長因子受體（EGFR）抑制劑在非小細胞肺癌、頭頸部腫瘤的治療方面取得了較好的療效。
Targeting EGFR pathway as a potential therapeutic strategy for pancreatic cancer has been developed.
以EGFR通路為靶點這樣一個對胰腺癌具有潛力的療法已經得到發展。
Objective To explore the expression change of protein and mRNA of EGFR(epidermal growth factor receptor)in RAU(recurrent aphthous ulcer).
目的觀察表皮生長因子受體（EGFR）在口腔復發性阿弗他潰瘍（RAU）組織中蛋白和基因表達變化。
Our study suggests a pivotal role of the EGFR-signalling pathway in regulating magnesium homoeostasis.
我們的研究顯示表皮生長因子受體信號途徑在體內調節鎂平衡發揮著關鍵作用。
Would you be more willing to conduct the EGFR mutation tests for your patients based on what you just read?
根據您剛才讀的內容，您是否會愿意讓您的患者進行EGFR突變檢測？
Objective: To explore the significance of abnormal expression of HB -EGF, EGFR in endometrium of unknown reason infertility.
目的：探討不明原因性不孕癥患者子宮內膜中HB-EGF及其受體的表達。
The invention provides a method for preparing a freeze-drying preparation of an EGFR-antibody.
本發明提供了抗EGFR-抗體的凍干制劑的制備方法。
The KRAS proto-oncogene product lies downstream of EGFR, and the mutation frees the receptor from normal regulation in cell-growth control.
原癌基因KRAS是表皮生長因子受體下游產物，它的突變使其不受在細胞生長控制中正常調節的受體影響。
Breast Cancer is the commonest malignant epithelial tumor for women. Breast Cancer also has high expression of EGFR.
乳腺癌做為女性最常見的惡性上皮性腫瘤，也有高表達EGFR。
Do regular pathology, VEGF, EGFR and immunohistochemical method CD34 expression and mark observation capillary is calculated.
做常規病理、VEGF、EGFR和CD34免疫組化方法標記觀察毛細血管表達情況并進行計算。
It targets a protein - epidermal growth factor receptor (EGFR) - which drives tumour growth.
它的目標是一種蛋白質：驅動腫瘤生長的表皮生長因子受體（EGFR）。
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
肺癌中表皮生長因子受體突變：吉非替尼治療的臨床反應。
Which of the following statements best describe your attitude towards EGFR mutation testing?
下列哪種說法最能代表您對EGFR基因突變檢測的看法？
Conclusion The inadequate expression and unproportional distribution of EGF and EGFR may be related to the incidence of hypospadias.
結論EGF、EGFR在包皮組織中的不足表達和不均衡分布可能與尿道下裂的發生有關。
Methods The expression of EGF and EGFR was detected in the prepuce tissue from 15 boys with hypospadias using immunohistochemical technique.
方法應用免疫組織化學染色方法對15例尿道下裂患兒包皮組織和尿道板中EGF、EGFR表達進行檢測。
Calcium image and inhibiting test were performed to show the mechanism of LPS induced EGFR phosphorylation.
鈣成像技術和鈣抑制實驗檢測鈣活動在LPS誘導的EGFR磷酸化中的作用；
